Meeting
2014 ASCO Annual Meeting
Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project.
Authors
John N. Weinstein
The University of Texas MD Anderson Cancer Center, Houston, TX
John N. Weinstein , Jaegil Kim , Chad J. Creighton , Rehan Akbani , Katherine A. Hoadley , William Y. Kim , Margaret B. Morgan , Toshinori Hinoue , Jonathan E. Rosenberg , Dean F. Bajorin , Donna E. Hansel , Hikmat Al-Ahmadie , Dmitry Gordenin , Joshua M. Stuart , Gordon Robertson , Raju Kucherlapati , Peter W. Laird , Gordon B. Mills , David J. Kwiatkowski , Seth P. Lerner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Bladder Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4509)
DOI
10.1200/jco.2014.32.15_suppl.4509
Abstract #
4509
Poster Bd #
1
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.
First Author: Jonathan E. Rosenberg
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2020 Genitourinary Cancers Symposium
Defining the genetic evolution of epigenetic alterations in bladder cancer.
First Author: Timothy Nguyen Clinton
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari